Vergleichende Wirksamkeit und Sicherheit von Baricitinib 2 mg und 4 mg bei Patienten mit aktiver rheumatoider Arthritis: Eine Bayes-Netzwerkmetaanalyse randomisierter, kontrollierter Studien

Translated title of the contribution: Comparative efficacy and safety of baricitinib 2 mg and 4 mg in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials

Y. H. Lee, S. C. Bae

    Research output: Contribution to journalArticlepeer-review

    15 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Comparative efficacy and safety of baricitinib 2 mg and 4 mg in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials'. Together they form a unique fingerprint.

    Medicine & Life Sciences